1348 related articles for article (PubMed ID: 21752789)
21. Basophilic inclusions and neuronal intermediate filament inclusions in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Ito H
Neuropathology; 2014 Dec; 34(6):589-95. PubMed ID: 24673472
[TBL] [Abstract][Full Text] [Related]
22. [TDP-43 proteinopathies: ALS and frontotemporal dementias].
Prudlo J
Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S25-7. PubMed ID: 19685386
[TBL] [Abstract][Full Text] [Related]
23. TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Baloh RH
FEBS J; 2011 Oct; 278(19):3539-49. PubMed ID: 21777387
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice.
Igaz LM; Kwong LK; Lee EB; Chen-Plotkin A; Swanson E; Unger T; Malunda J; Xu Y; Winton MJ; Trojanowski JQ; Lee VM
J Clin Invest; 2011 Feb; 121(2):726-38. PubMed ID: 21206091
[TBL] [Abstract][Full Text] [Related]
25. Premature death of TDP-43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis.
Esmaeili MA; Panahi M; Yadav S; Hennings L; Kiaei M
Int J Exp Pathol; 2013 Feb; 94(1):56-64. PubMed ID: 23317354
[TBL] [Abstract][Full Text] [Related]
26. Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice.
Medina DX; Orr ME; Oddo S
Neurobiol Aging; 2014 Jan; 35(1):79-87. PubMed ID: 23954172
[TBL] [Abstract][Full Text] [Related]
27. TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration.
Fiesel FC; Kahle PJ
FEBS J; 2011 Oct; 278(19):3550-68. PubMed ID: 21777389
[TBL] [Abstract][Full Text] [Related]
28. MTHFSD and DDX58 are novel RNA-binding proteins abnormally regulated in amyotrophic lateral sclerosis.
MacNair L; Xiao S; Miletic D; Ghani M; Julien JP; Keith J; Zinman L; Rogaeva E; Robertson J
Brain; 2016 Jan; 139(Pt 1):86-100. PubMed ID: 26525917
[TBL] [Abstract][Full Text] [Related]
29. The heat shock response plays an important role in TDP-43 clearance: evidence for dysfunction in amyotrophic lateral sclerosis.
Chen HJ; Mitchell JC; Novoselov S; Miller J; Nishimura AL; Scotter EL; Vance CA; Cheetham ME; Shaw CE
Brain; 2016 May; 139(Pt 5):1417-32. PubMed ID: 26936937
[TBL] [Abstract][Full Text] [Related]
30. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.
Cooper-Knock J; Hewitt C; Highley JR; Brockington A; Milano A; Man S; Martindale J; Hartley J; Walsh T; Gelsthorpe C; Baxter L; Forster G; Fox M; Bury J; Mok K; McDermott CJ; Traynor BJ; Kirby J; Wharton SB; Ince PG; Hardy J; Shaw PJ
Brain; 2012 Mar; 135(Pt 3):751-64. PubMed ID: 22366792
[TBL] [Abstract][Full Text] [Related]
31. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
[TBL] [Abstract][Full Text] [Related]
32. Clinical and pathological continuum of multisystem TDP-43 proteinopathies.
Geser F; Martinez-Lage M; Robinson J; Uryu K; Neumann M; Brandmeir NJ; Xie SX; Kwong LK; Elman L; McCluskey L; Clark CM; Malunda J; Miller BL; Zimmerman EA; Qian J; Van Deerlin V; Grossman M; Lee VM; Trojanowski JQ
Arch Neurol; 2009 Feb; 66(2):180-9. PubMed ID: 19204154
[TBL] [Abstract][Full Text] [Related]
33. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.
Walker AK; Spiller KJ; Ge G; Zheng A; Xu Y; Zhou M; Tripathy K; Kwong LK; Trojanowski JQ; Lee VM
Acta Neuropathol; 2015 Nov; 130(5):643-60. PubMed ID: 26197969
[TBL] [Abstract][Full Text] [Related]
34. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration.
Wegorzewska I; Bell S; Cairns NJ; Miller TM; Baloh RH
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18809-14. PubMed ID: 19833869
[TBL] [Abstract][Full Text] [Related]
35. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
Takeda T
Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
[TBL] [Abstract][Full Text] [Related]
36. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies.
Geser F; Lee VM; Trojanowski JQ
Neuropathology; 2010 Apr; 30(2):103-12. PubMed ID: 20102519
[TBL] [Abstract][Full Text] [Related]
37. The frontotemporal syndromes of ALS. Clinicopathological correlates.
Strong MJ; Yang W
J Mol Neurosci; 2011 Nov; 45(3):648-55. PubMed ID: 21809041
[TBL] [Abstract][Full Text] [Related]
38. TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.
Cai M; Lee KW; Choi SM; Yang EJ
Neurol Res; 2015 Mar; 37(3):253-62. PubMed ID: 25213598
[TBL] [Abstract][Full Text] [Related]
39. [Neuropathological similarities and differences between frontotemporal lobar degeneration with ubiquitin inclusions and amyotrophic lateral sclerosis with dementia].
Tan CF; Toyoshima Y; Kakita A; Takahashi H
Brain Nerve; 2009 Nov; 61(11):1319-27. PubMed ID: 19938689
[TBL] [Abstract][Full Text] [Related]
40. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Igaz LM; Kwong LK; Xu Y; Truax AC; Uryu K; Neumann M; Clark CM; Elman LB; Miller BL; Grossman M; McCluskey LF; Trojanowski JQ; Lee VM
Am J Pathol; 2008 Jul; 173(1):182-94. PubMed ID: 18535185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
